Shoichi Iriguchi

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation.

Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation.

Journal: Frontiers in immunology
Published: May 17, 2026

Adaptive-like CAR-iPSC-CD4⁺ T cells outperform CD8⁺ counterparts in sustained ALL control.

Adaptive-like CAR-iPSC-CD4⁺ T cells outperform CD8⁺ counterparts in sustained ALL control.

Journal: Inflammation and regeneration
Published: October 05, 2025

Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation.

Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation.

Journal: Frontiers in immunology
Published: June 24, 2025

Artificial thymic organoid culture generates functional iPSC-derived CD4+ invariant natural killer T cells.

Artificial thymic organoid culture generates functional iPSC-derived CD4+ invariant natural killer T cells.

Journal: Communications biology
Published: February 20, 2024

Effective and stable gene transduction in rhesus macaque iPSCs capable of T-lineage differentiation utilizing the piggyBac system.

Effective and stable gene transduction in rhesus macaque iPSCs capable of T-lineage differentiation utilizing the piggyBac system.

Journal: Regenerative therapy
Published: January 17, 2024

Lineage tracing of T cell differentiation from T-iPSC by 2D feeder-free culture and 3D organoid culture.

Lineage tracing of T cell differentiation from T-iPSC by 2D feeder-free culture and 3D organoid culture.

Journal: Frontiers in immunology
Published: September 28, 2023

Human iPSC-derived CD4+ Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model.

Human iPSC-derived CD4+ Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model.

Journal: Cell stem cell
Published: September 17, 2022

Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells.

Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells.

Journal: Nature biomedical engineering
Published: December 21, 2021

The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-1derived iPS cells.

The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-1derived iPS cells.

Journal: Communications biology
Published: November 09, 2020

Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease.

Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease.

Journal: Molecular therapy. Methods & clinical development
Published: May 28, 2020

Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells.

Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells.

Journal: Nature biomedical engineering
Published: December 05, 2019

Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.

Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.

Journal: Cancer science
Published: November 28, 2019
Showing 1-12 of 23

Last Updated: 09/26/2026